A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men

por Swerdloff, Ronald S., Dudley, Robert E.
Publicado 2020

Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels

por Swerdloff, Ronald S., Dudley, Robert E., Page, Stephanie T., Wang, Christina, Salameh, Wael A.
Publicado 2017

SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters

por Swerdloff, Ronald S, Amory, John K, Dobs, Adrian S, Wang, Christina, Danoff, Theodore M, Dudley, Robert E
Publicado 2020

Safety Analysis of an Oral Testosterone Undecanoate (TU) Formulation Following 2 Years of Administration in Hypogonadal Men

por Swerdloff, Ronald S, Amory, John K, Gittelman, Marc, Seo, B Woun, Rohowsky, Nestor, Dudley, Robert E
Publicado 2021

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men

por Swerdloff, Ronald S, Wang, Christina, White, William B, Kaminetsky, Jed, Gittelman, Marc C, Longstreth, James A, Dudley, Robert E, Danoff, Theodore M
Publicado 2020